Bovine aortic smooth muscle cells in vitro responded to 1 nM to 10 ,M serotonin with increased incorporation of [3H]thymidine into DNA. The mitogenic effect of serotonin was half-maximal at 80 nM and maximal above 1 ,uM. At a concentration of 1 ,uM, serotonin stimulated smooth muscle cell mitogenesis to the same extent as human plateletderived growth factor (PDGF) at 12 ng/ml, Tryptamine was =1/10th as potent as serotonin as a mitogen for smooth muscle cells. Other indoles that are structurally related to serotonin (Dand L-tryptophan, 5-hydroxy-L-tryptophan, N-acetyl-5-hydroxytryptamine, melatonin, 5-hydroxyindoleacetic acid, and 5-hydroxytryptophol) and quipazine were inactive. The stimulatory effect of serotonin on smooth muscle cell DNA synthesis required prolonged (20-24 hr) [3HlThymidine Incorporation. Bovine aortic smooth muscle cells from frozen stock (passages 3-12) were suspended in Dulbecco's modified Eagle's medium (DMEM) (pH 7.4) supplemented with 10% calf serum/6 mM glutamine/ penicillin (100 units/ml)/streptomycin (100 pug/ml) for seeding into 16-mm 96-well microtiter plates at a density of w50,000 cells per well. After 48 hr, the growth medium was replaced with serum-free quiescing medium consisting of DMEM and Ham's F12 (1:1; pH 7.4) supplemented with ovalbumin (1 mg/ml)/ascorbic acid (25 ,ug/ml)/selenium (25 ng/ml)/dialyzed Cohn fraction IV (10 ug/ml)/epidermal growth factor (10 ng/ml)/transferrin 10 ,tg/ml) 50 ,uM hydrocortisone/6 mM glutamine/penicillin (100 units/ml)/ streptomycin (100 ,ug/ml) (8). Smooth muscle cells were incubated in the quiescing medium for 96 hr. The medium was changed once during this period. Compounds to be tested were added to smooth muscle cells in quiescing medium 1 hr before serotonin and/or PDGF. The cultures were exposed to serotonin and/or PDGF for 20 hr before [3H]thymidine (2.0 ,uCi/ml; 1 Ci = 37 GBq) was included in the quiescing medium. Four hours after the addition of [3H]thymidine, experiments were terminated by aspirating the medium and subjecting the cultures to sequential washes with Dulbecco's phosphate-buffered saline (pH 7.4) containing 1 mM CaCl2, 1 mM MgCl2, 10% trichloroacetic acid, and ethanol/ether (2:1). Phase-contrast microscopy was used to inspect the microwells for evidence of cell detachment or changes in cell morphology. Acid-insoluble [3H]thymidine was extracted into 0.5 M NaOH and quantified by using a liquid scintillation counter.
submaximal concentrations ofserotonin and PDGF, synergistic rather than additive mitogenic responses were observed. These data indicate that serotonin has a significant mitogenic effect on smooth muscle cells in vitro, which appears to be mediated by specific plasma membrane receptors.
Interactions between blood cells and the arterial wall have been proposed as early events in atherogenesis (1) (2) (3) . The possibility that cell-derived growth factors are involved in the initiation and progression of the myointimal lesions, which are characteristic of atherosclerosis, has received particular attention. Recent work has focused on platelet-derived growth factor (PDGF), a potent mitogen for vascular smooth muscle cells in vitro (4, 5) that is thought to be released from the a granules ofplatelets adhering to exposed subendothelial connective tissue or foam cells (2, 3) . Prior to the onset of DNA synthesis, PDGF elicits a variety of responses in aortic smooth muscle cells, including increased prostacyclin biosynthesis (6). Coughlin et al. (6) have reported that the prostacyclin response to PDGF is potentiated in the presence of serotonin, which is also released during platelet degranulation. This observation suggested that serotonin might influence the magnitude of the smooth muscle cell mitogenic response to PDGF. The present investigation was undertaken to evaluate this hypothesis.
EXPERIMENTAL PROCEDURES Cell Cultures. Bovine aortic smooth muscle cells were propagated from medial explants essentially as described by Ross and Karlya (7) . The cultures showed focal areas of overgrowth and prominent bundles of myofilaments, both of which are characteristic of vascular smooth muscle cells in vitro. All incubations were carried out at 37°C under a humidified atmosphere of 95% air/5% CO2.
[3HlThymidine Incorporation. Bovine aortic smooth muscle cells from frozen stock (passages 3-12) were suspended in Dulbecco's modified Eagle's medium (DMEM) (pH 7.4) supplemented with 10% calf serum/6 mM glutamine/ penicillin (100 units/ml)/streptomycin (100 pug/ml) for seeding into 16 -mm 96-well microtiter plates at a density of w50,000 cells per well. After 48 hr, the growth medium was replaced with serum-free quiescing medium consisting of DMEM and Ham's F12 (1:1; pH 7.4) supplemented with ovalbumin (1 mg/ml)/ascorbic acid (25 ,ug/ml)/selenium (25 ng/ml)/dialyzed Cohn fraction IV (10 ug/ml)/epidermal growth factor (10 ng/ml)/transferrin 10 ,tg/ml) 50 ,uM hydrocortisone/6 mM glutamine/penicillin (100 units/ml)/ streptomycin (100 ,ug/ml) (8) . Smooth muscle cells were incubated in the quiescing medium for 96 hr. The medium was changed once during this period. Compounds to be tested were added to smooth muscle cells in quiescing medium 1 hr before serotonin and/or PDGF. The cultures were exposed to serotonin and/or PDGF for 20 hr before [3H]thymidine (2.0 ,uCi/ml; 1 Ci = 37 GBq) was included in the quiescing medium. Four hours after the addition of [3H]thymidine, experiments were terminated by aspirating the medium and subjecting the cultures to sequential washes with Dulbecco's phosphate-buffered saline (pH 7.4) containing 1 mM CaCl2, 1 mM MgCl2, 10% trichloroacetic acid, and ethanol/ether (2:1). Phase-contrast microscopy was used to inspect the microwells for evidence of cell detachment or changes in cell morphology. Acid-insoluble [3H]thymidine was extracted into 0.5 M NaOH and quantified by using a liquid scintillation counter.
Materials. Serotonin, tryptamine, L-tryptophan, Dtryptophan, N-acetyl-5-hydroxytryptamine, 5-hydroxy-Ltryptophan, melatonin, 5-hydroxyindoleacetic acid, 5- hydroxytryptophol, propranolol, atropine, cimetidine, 1-methyl-3-isobutylxanthine, ovalbumin, and Cohn fraction IV were obtained from Sigma; quipazine ( taining 0.6 mM ascorbic acid, 1 mM pargyline, 6 mM glutamine, 100 units of penicillin per ml, and 100 Ag of streptomycin per ml immediately before the beginning of an experiment. DMEM containing 2 mg of bovine serum albumin per ml was the diluent for PDGF, BW501C, propranolol, phentolamine, cimetidine, and atropine. 1-Methyl-3-isobutylxanthine and 32-550 were solubilized in dimethyl sulfoxide. Forskolin was dissolved in absolute ethanol. The final concentration of dimethyl sulfoxide or ethanol in any assay system did not exceed 0.1%.
RESULTS
In agreement with Williams et al. (5), we observed that bovine aortic smooth muscle cells in vivo responded to human PDGF with concentration-dependent increases in
[3H]thymidine incorporation into DNA (Fig. 1) a number of other indoles that were examined.
Serotonin-induced increases in smooth muscle cell DNA synthesis required prolonged exposure to the agonist. In the experiment summarized in Fig. 3, [3H] thymidine incorporation in smooth muscle cultures exposed to 0.1 ,uM serotonin for 3, 6, 9, or 12 hr was comparable to the control value. Enhanced mitogenesis was observed when serotonin was included in smooth muscle cell incubation medium for 20 hr. Under these conditions, however, the mitogenic response to serotonin was attenuated relative to that seen when the indole was present for 24 hr.
Serotonin appeared to stimulate smooth muscle cell mitogenesis by interacting with specific plasma membrane receptors. The stimulatory effect of 0.3 ,uM serotonin on [3H]thymidine incorporation was markedly attenuated in the presence of either BW501C (0.01-10 AM) or the ergot derivative 32-550 (0.1-10 ,M) (Fig. 4) . BW501C has been reported to selectively antagonize radioligand binding to type 2 serotonin D receptors (11) . 32-550 has been found to inhibit vascular responses mediated by serotonin D receptors (B. P. Richardson, personal communication). The mitogenic response to 10 ng/ml PDGF was maintained and, in some cases, slightly increased in smooth muscle cells exposed to concentrations of BW5O1C or 32-550 below 10 AuM.
In contrast to the response to serotonin D receptor antagonists, serotonin M receptor antagonists did not significantly affect the mitogenic response to the indole even at concentrations as high as 100 ,.M (data not shown). As indicated in Table 2 , 1-methyl-3-isobutylxanthine and forskolin decreased serotonin-stimulated [3H]thymidine incorporation into DNA. Since 1-methyl-3-isobutylxanthine and forskolin would be expected to potentiate cyclic AMP-mediated responses (12, 13) , this observation was consistent with the activation of type 2 serotonin D receptors that are not coupled to adenylate cyclase (14) . Neither propranolol (a P-adrenergic receptor antagonist), atropine (a muscarinic cholinergic receptor antagonist), nor cimetidine (an H2 receptor antagonist) blocked the stimulatory effect of serotonin. Phentolamine, an a-adrenergic receptor antagonist with anti-serotonergic activity, suppressed the mitogenic response to the indole.
The interaction between serotonin and PDGF on smooth muscle cell mitogenesis is shown in Fig. 5 was comparable to that seen with PDGF at 12 ng/ml. If the molecular weight of PDGF is taken to be 30,000-33,000 (15) (16) (17) (18) , 12 ng/ml corresponds to a concentration of ==0.5 nM. Serotonin was therefore a less potent and less effective mitogen for smooth muscle cells in vitro than PDGF. However, serotonin showed mitogenic activity at concentrations that are comparable to those found in human platelet-poor plasma (19) . Thus, serotonin could be an important in vivo determinant of vascular smooth muscle cell proliferation. In this regard, it is interesting that serotonin-producing neoplasms (argentaffmiomas) in man are associated with fibrous cardiovascular lesions, which are composed largely of smooth muscle cells (20) .
Significant in vitro stimulation of smooth muscle cell DNA synthesis by serotonin depended on prolonged activation of specific membrane receptors. PDGF-stimulated mitogenesis in human foreskin fibroblasts has also been found to require the interaction of the growth factor with its receptor for the major part of the Go/G1 phase (C. H. Heldin, personal communication). In contrast, BALB/c 3T3 fibroblasts proliferate after only transient exposure to PDGF if "progression factors" such as epidermal growth factor and somatomedin C are included in the incubation medium (22, 23) . Antagonism of the smooth muscle cell mitogenic response to serotonin by BW501C or 32-550 implies that it is mediated by type 2 serotonin D receptors. This conclusion is supported by data that showed the stimulatory effect of serotonin on smooth muscle cell mitogensis was not mimicked by agents that increase intracellular cyclic AMP levels and was not blocked by serotonin M receptor antagonists.
The synergistic effects of submaximal concentrations of serotonin and PDGF on smooth muscle cell mitogenesis and, as previously reported by Coughlin et al. (6) , on smooth muscle cell prostaglandin biosynthesis suggest that the proliferative responses may be mediated, at least in part, by metabolites of arachidonic acid. In this regard, it is noteworthy that smooth muscle cells exposed to serotonin show dramatic increases in prostacyclin biosynthesis long before they initiate DNA synthesis (24) . Moreover, the prostacyclin response to serotonin, like the mitogenic response to the indole, appears to involve activation of type 2 serotonin D receptors (24) . Some experimental support for the idea that arachidonic acid metabolites may serve as intracellular signals for mitogens comes from the work of Shier and Durkin (21) . These investigators obtained similar IC50 values for phenylglyoxal inhibition of PDGF-stimulated arachidonate metabolism, prostaglandin release, and DNA synthesis in 3T3 fibroblasts. However, we have not observed significant effects of 10-100 ,uM prostacyclin, 0.1-5 ,uM indomethacin, 0.1-1 ,M 5,8,11,14-icosatetraenoic acid, or 100 ,uM phenylglyoxal on the smooth muscle cell mitogenic response to PDGF (unpublished data). Ongoing studies have indicated that serotonin (0.1 nM to 1 ,uM) does not enhance the specific binding of '251-labeled PDGF to smooth muscle cells (unpublished data).
Synergistic mitogenic responses to serotonin and PDGF in vivo could have important implications with regard to the development and progression of atherosclerosis. Both serotonin and PDGF may be released from platelets that adhere to the vessel wall during the early stages of atherogenesis (2, 3). Ross et al. (4) have hypothesized that PDGF initiates myointimal lesion formation by stimulating the proliferation of vascular smooth muscle cells. Potentiation of the mitogenic effect of PDGF by serotonin would be expected to facilitate the disease process by increasing the sensitivity of vascular smooth muscle to low local concentrations of the growth factor.
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